
Common Medications Linked to Worse Survival in Lung Cancer Patients Receiving Keytruda
Use of certain antibiotics, steroids and proton pump inhibitors (PPIs) at the start of immunotherapy was associated with shorter survival in patients with advanced non-small cell lung cancer (NSCLC), according to a nationwide cohort study from France …